Monthly information on share capital and company voting rights
Cellectis (CLLS) has released its monthly share capital and voting rights report as of August 31, 2025. The company reported a total of 100,325,229 shares in its capital structure and 89,428,230 voting rights. This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority for companies listed on Euronext Growth.
Cellectis (CLLS) ha pubblicato il proprio rapporto mensile sul capitale azionario e sui diritti di voto aggiornato al 31 agosto 2025. La società comunica un totale di 100.325.229 azioni e 89.428.230 diritti di voto. Questa informazione è fornita in conformità all'articolo 223-16 del Regolamento Generale dell'autorità dei mercati finanziari francese per le società quotate su Euronext Growth.
Cellectis (CLLS) ha publicado su informe mensual sobre el capital social y los derechos de voto a fecha de 31 de agosto de 2025. La compañía informa de un total de 100.325.229 acciones y 89.428.230 derechos de voto. Esta comunicación se realiza de conformidad con el artículo 223-16 del Reglamento General de la autoridad francesa de mercados financieros para las empresas cotizadas en Euronext Growth.
Cellectis (CLLS)는 2025년 8월 31일 기준 월간 자본 및 의결권 보고서를 공시했습니다. 회사는 자본에 총 100,325,229주와 89,428,230개의 의결권이 있음을 보고했습니다. 이 공개는 Euronext Growth에 상장된 기업에 적용되는 프랑스 금융시장청의 일반규정 제223-16조에 따라 이루어졌습니다.
Cellectis (CLLS) a publié son rapport mensuel sur le capital social et les droits de vote au 31 août 2025. La société indique détenir au total 100 325 229 actions et 89 428 230 droits de vote. Cette divulgation est effectuée conformément à l'article 223-16 du Règlement Général de l'autorité des marchés financiers française pour les sociétés cotées sur Euronext Growth.
Cellectis (CLLS) hat seinen monatlichen Bericht über das Aktienkapital und die Stimmrechte zum 31. August 2025 veröffentlicht. Das Unternehmen meldet insgesamt 100.325.229 Aktien und 89.428.230 Stimmrechte. Diese Mitteilung erfolgt gemäß Artikel 223-16 der Allgemeinen Verordnung der französischen Finanzmarktaufsichtsbehörde für an Euronext Growth notierte Gesellschaften.
- None.
- None.
PARIS, Sept. 03, 2025 (GLOBE NEWSWIRE) --
(Article 223-16 of General Regulation of the French financial markets authority)
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 08/31/2025 | 100,325,229 | 89,428,230 |
For further information on Cellectis, please contact:
Media contacts:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contact:
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com
Attachment
FAQ
What is the current total number of shares outstanding for Cellectis (CLLS)?
How many voting rights does Cellectis (CLLS) have as of August 2025?
Why is there a difference between Cellectis (CLLS) total shares and voting rights?
How often does Cellectis (CLLS) report its share capital and voting rights information?
